Status:
COMPLETED
Evaluation of Utility of Ultrasound Guided iPACK Block for Knee Extension After Total Knee Arthroplasty.
Lead Sponsor:
Duke University
Conditions:
Knee Osteoarthritis
Primary Total Knee Arthroplasty
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to learn if using an Interspace between the Popliteal Artery and Capsule of the Knee (iPACK) injection technique (also called a "nerve block") that numbs the nerves going ...
Eligibility Criteria
Inclusion
- English speaking
- Between 18 and 75 years old
- American Society of Anesthesiologists (ASA) 1-3 patients undergoing primary total knee arthroplasty
Exclusion
- ASA 4 or 5
- Revision knee arthroplasty
- Diagnosis of chronic pain
- Daily chronic opioid use (over 3 months of continuous opioid use)
- Inability to communicate pain scores or need for analgesia
- Acute knee dislocation/fracture
- Infection at the site of block placement
- Age under 18 years old or greater than 75 years old
- Pregnant women
- Intolerance/allergy to local anesthetics
- Weight \<50 kg
- Suspected, or known addiction to or abuse of illicit drug(s), prescription medicine(s), or alcohol within the past 2 years.
- Uncontrolled anxiety, schizophrenia, or other psychiatric disorder that, in the opinion of the investigator, may interfere with study assessments or compliance
- Current or historical evidence of any clinically significant disease or condition that, in the opinion of the investigator, may increase the risk of surgery or complicate the subject's postoperative course.
Key Trial Info
Start Date :
May 3 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 23 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03353233
Start Date
May 3 2018
End Date
January 23 2021
Last Update
December 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Hospital
Durham, North Carolina, United States, 27713